Novo Nordisk A/S Sponsored ADR logo

Novo Nordisk A/S Sponsored ADR (NVON)

Market Closed
24 Feb, 20:00
XMEX XMEX
MX$
663. 80
-21.85
-3.19%
MX$
- Market Cap
48.26 P/E Ratio
0.56% Div Yield
7,419 Volume
0 Eps
MX$ 685.65
Previous Close
Day Range
662 685.05
Year Range
662 1,925
Want to track NVON and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NVON earnings report is expected in 70 days (5 May 2026)
Name Time Cons. EPS Eps
Novo Nordisk A/S Sponsored ADR logo
NVON Novo Nordisk A/S Sponsored ADR
6 May 2026 (In 2 months)
4.94
-
Novo Nordisk A/S Sponsored ADR logo
NVON Novo Nordisk A/S Sponsored ADR
5 May 2026 (In 2 months)
-
-
Novo Nordisk A/S Sponsored ADR logo
NVON Novo Nordisk A/S Sponsored ADR
4 Feb 2026
5.9
17.24
Novo Nordisk A/S Sponsored ADR logo
NVON Novo Nordisk A/S Sponsored ADR
5 Nov 2025
4.24
13.12
Novo Nordisk A/S Sponsored ADR logo
NVON Novo Nordisk A/S Sponsored ADR
6 Aug 2025
6.01
17.68
Novo Nordisk A/S Sponsored ADR logo
NVON Novo Nordisk A/S Sponsored ADR
7 May 2025
-
-

NVON Earnings Reports FAQ

What is the earnings per share (EPS) for NVON?

The current EPS is 0.

What is the company's earnings growth rate?

Novo Nordisk A/S Sponsored ADR has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-05-05, based on the NVON's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings were 17.2392 per share, reported on 2026-02-04. For dividend history, visit the NVON Dividends page.

What is the price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio is 38.51, calculated based on the most recent stock price of MX$663.80.